JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS - Journal - Bridge of Knowledge

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

ISSN:

0022-3565

eISSN:

1521-0103

Disciplines
(Field of Science):

biomedical engineering (Engineering and Technology)
medical biology (Medical and Health Sciences )
pharmacology and pharmacy (Medical and Health Sciences )
medical sciences (Medical and Health Sciences )
health sciences (Medical and Health Sciences )
food and nutrition technology (Agricultural sciences)
biotechnology (Natural sciences)
biological sciences (Natural sciences)
chemical sciences (Natural sciences)

expand collapse

Ministry points: Help

Ministry points - current year
Year	Points	List
Year 2024	140	Ministry scored journals list 2024

expand collapse

Ministry points - previous years
Year	Points	List
2024	140	Ministry scored journals list 2024
2023	140	Ministry Scored Journals List
2022	140	Ministry Scored Journals List 2019-2022
2021	140	Ministry Scored Journals List 2019-2022
2020	140	Ministry Scored Journals List 2019-2022
2019	140	Ministry Scored Journals List 2019-2022
2018	35	A
2017	35	A
2016	35	A
2015	35	A
2014	35	A
2013	35	A
2012	35	A
2011	35	A
2010	32	A

Model:

Hybrid

Points CiteScore:

Points CiteScore - current year
Year	Points
Year 2022	8.4

expand collapse

Points CiteScore - previous years
Year	Points
2022	8.4
2021	7.1
2020	6.4
2019	5.9
2018	6.8
2017	7.4
2016	7.5
2015	8.3
2014	8.3
2013	8.3
2012	7.8
2011	7.7

Impact Factor:

Log in to see the Impact Factor.

Sherpa Romeo:

https://v2.sherpa.ac.uk/id/publication/9890

Papers published in journal

results on page:
year:
- selected sort by year newest first
- sort by year oldest first
title:
- selected sort by title A-Z
- sort by title Z-A
citation:
- sort by citation descending
- sort by citation ascending

Filters

total: 1

Year 2013

DNA-damaging imidazoacridinone C-1311 induces autophagy followed by irreversible growth arrest and senescence in human lung cancer cells
Publication
- J. Polewska
- A. Skwarska
- E. Augustin
- J. Konopa
- JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS - Year 2013
Imidazoacridinone 5-diethylaminoethylamino-8-hydroxyimidazoacridinone (C-1311) is an antitumor inhibitor of topoisomerase II and FMS-like tyrosine kinase 3 receptor. In this study, we describe the unique sequence of cellular responses to C-1311 in human non-small cell lung cancer (NSCLC) cell lines, A549 and H460. In A549 cells, C-1311 (IC80 = 0.08 µM) induced G1 and G2/M arrests, whereas H460 cells (IC80 = 0.051 µM) accumulated...

Full text to download in external service

seen 324 times